Last updated 2026-07-27
- Raised $7.2M Series A, Nov 2018
- Raised $2.5M grant, Apr 2022
- Raised $4M Series C led by Guangzhou Sino-Israel Biotech Investment Fund (GIBF), Jul 2021
Total raised
$18.8M
Last: Grant 2022-05
Stage
Series B
Founded
2015
Headcount
18
HQ
Ra'anana, Israel
Sector
Health Tech & Life Sciences
About
CorNeat Vision is an Israeli ophthalmic medical device company developing synthetic, tissue-integrating implants to address unmet needs in cornea, glaucoma, and ocular surface surgery. Their products, which include an artificial cornea, a synthetic scleral patch, and a glaucoma drainage device, leverage their proprietary EverMatrix™ technology to seamlessly integrate with living tissue, offering long-lasting solutions that restore and preserve vision.
Funding history · 7 rounds · $18.8M total
2022-04
Grant
$2.5M
2021-07
C Round
$4.0M
★ Guangzhou Sino-Israel Biotech Investment Fund (GIBF)
2020-04
B Round
$3.4M
2018-11
A Round
$7.2M
2018-03
Grant
$200K
2017-10
Grant
$15K
2017-10
Seed
$1.4M
Headcount over time
From 3 (2018-11) to 18 (2026-03) · +15 (+500%) · 15 points · source: Finder history + radar grounding
Q&A
- What is CorNeat Vision's primary focus?
- CorNeat Vision is a medical device company that develops and markets novel, permanent, and tissue-integrating implants. Their core technology, CorNeat EverMatrix™, is designed to overcome the foreign body response typically triggered by implants.
- When was CorNeat Vision founded?
- CorNeat Vision was founded in December 2015.
- How many employees does CorNeat Vision have?
- CorNeat Vision has 11-50 employees.
- What is CorNeat Vision's total funding to date?
- CorNeat Vision has raised a total of $18,765,000 across multiple funding rounds.
- When was CorNeat Vision's most recent funding round and who were the lead investors?
- CorNeat Vision's most recent funding was a grant of $2,500,000 from the European Commission in May 2022.
- Which investor participated in CorNeat Vision's August 2021 funding round?
- Guangzhou Sino-Israel Biotech Investment Fund (GIBF) participated in CorNeat Vision's $4,000,000 funding round in August 2021.
- Who are the co-founders of CorNeat Vision?
- The co-founders of CorNeat Vision are Gilad Litvin, who serves as Co-founder, Chairman, and Chief Medical Officer, and Almog Aley-raz, who is Co-founder, CEO, and VP R&D.
- What is CorNeat Vision's primary sector?
- CorNeat Vision's primary sector is Health Tech & Life Sciences.
Team · 2
Gilad Litvin
Founder · Co-Founder, Chief Medical Officer
Almog Aley-Raz
Founder · Co-Founder, CEO and VP R&D
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
healthcaremedical-devicesvisually-impairedeye-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | corneat.com/ |
|---|---|
| linkedin.com/company/18006267 | |
| YouTube | youtube.com/channel/UCo1Ma47GaQ5zecSC98a9vbw |
Identifiers & details
| Founded | 2015-12 |
|---|---|
| Employees (exact) | 18 |
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | corneat.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515356293 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-12-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 7 — shares_capital (2), violation (1), charge (2), other (1), people (1) |
| Registered address | השיזף 4 רעננה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-25 | הקצאת מניות |
| 2026-06-25 | עדכון הפרה |
| 2026-01-25 | העברת מניות |
| 2026-02-23 | רישום שעבוד |
| 2025-07-07 | סילוק שעבוד |
| 2026-01-06 | שינוי בתקנון |
| 2026-01-05 | עדכון דירקטורים-הסרת דירקטור |